Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Steatohepatitis NASH”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05513729
What this trial is testing

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Not applicableUnknownNCT02644239
What this trial is testing

Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy

Who this might be right for
EpilepsyCardiovascular DiseaseNon-alcoholic Fatty Liver Disease+1 more
University of Sao Paulo 60
Not applicableUnknownNCT01922830
What this trial is testing

Probiotics and Microbiota in Bariatric Surgery

Who this might be right for
NAFLD
Tel-Aviv Sourasky Medical Center 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04822181
What this trial is testing

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis
Novo Nordisk A/S 1,205
Post-approval studies (Phase 4)Study completedNCT04977661
What this trial is testing

Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Kafrelsheikh University 102
Testing effectiveness (Phase 2)Study completedNCT04210245
What this trial is testing

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 160
Testing effectiveness (Phase 2)Study completedNCT05463575
What this trial is testing

Ketohexokinase Inhibition in NAFLD

Who this might be right for
NAFLD
Maastricht University Medical Center 15
Not applicableStudy completedNCT03490370
What this trial is testing

Proof of Concept ELectro-Stimulation of Muscles to resolVe Insulin Resistance in NASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisInsulin Sensitivity
NHS Tayside 8
Testing effectiveness (Phase 2)Study completedNCT03812029
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis
Enyo Pharma 120
Not applicableLooking for participantsNCT06707129
What this trial is testing

Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal

Who this might be right for
Non-alcoholic Fatty Liver Disease
Beijing Municipal Administration of Hospitals 50
Large-scale testing (Phase 3)Study completedNCT01277237
What this trial is testing

The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Edinburgh 50
Post-approval studies (Phase 4)Looking for participantsNCT06374875
What this trial is testing

Fibrosis Lessens After Metabolic Surgery

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)+2 more
The Cleveland Clinic 120
Not applicableUnknownNCT03760172
What this trial is testing

Immunomediated Non-alcoholic SteaTohepatitis; Prevalence and Characterization. INSTInCT Study

Who this might be right for
Main Hypothesis is That in the NASH Associated to IMIDs, to Different Phenotypes co Exist
Instituto de Investigación Marqués de Valdecilla 7,300
Not applicableUnknownNCT05798702
What this trial is testing

Fibrosis Reduction in Non Alcoholic Steatohepatitis

Who this might be right for
NASH With FibrosisWeight LossBariatric Surgery Candidate
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Not applicableLooking for participantsNCT05385237
What this trial is testing

Identification of Hepatic Fibrosis Using 4D-MRI

Who this might be right for
Liver Diseases
University Hospital, Basel, Switzerland 200
Very early researchActive Not RecruitingNCT06373523
What this trial is testing

MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin

Who this might be right for
Hepatic Steato-FibrosisNon-Alcoholic Fatty Liver Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Not applicableLooking for participantsNCT06671886
What this trial is testing

NAFLD Clinical Care Pathway

Who this might be right for
NAFLDMASLD
VA Office of Research and Development 32
Large-scale testing (Phase 3)UnknownNCT04193982
What this trial is testing

An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
NAFLD
Asian Institute of Gastroenterology, India 250
Not applicableUnknownNCT02663388
What this trial is testing

Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)

Who this might be right for
ObesityDiabetesMetabolic Diseases+1 more
University of Lorraine 20,000
Very early researchStudy completedNCT02726542
What this trial is testing

Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

Who this might be right for
NAFLD
Massachusetts General Hospital 24
Next Page